[go: up one dir, main page]

WO2012108748A3 - Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin - Google Patents

Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin Download PDF

Info

Publication number
WO2012108748A3
WO2012108748A3 PCT/KR2012/001082 KR2012001082W WO2012108748A3 WO 2012108748 A3 WO2012108748 A3 WO 2012108748A3 KR 2012001082 W KR2012001082 W KR 2012001082W WO 2012108748 A3 WO2012108748 A3 WO 2012108748A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
brain cancer
albizzia julibrissin
cosmetic composition
treating brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/001082
Other languages
English (en)
Korean (ko)
Other versions
WO2012108748A2 (fr
Inventor
황성연
정경채
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOREA BIO MEDICAL SCIENCE INSTITUTE
Original Assignee
KOREA BIO MEDICAL SCIENCE INSTITUTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOREA BIO MEDICAL SCIENCE INSTITUTE filed Critical KOREA BIO MEDICAL SCIENCE INSTITUTE
Publication of WO2012108748A2 publication Critical patent/WO2012108748A2/fr
Publication of WO2012108748A3 publication Critical patent/WO2012108748A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une nouvelle utilisation d'un extrait d'Albizzia julibrissin et concerne notamment une composition pour prévenir et guérir le cancer du cerveau, la composition comprenant un extrait éthanolique d'Albizzia julibrissin en tant qu'ingrédient actif, et une composition cosmétique pour prévenir le cancer du cerveau, la composition cosmétique comprenant l'extrait éthanolique d'Albizzia julibrissin, qui comprend un additif de supplément cosmétique acceptable en cosmétologie en tant qu'ingrédient actif. La composition et la composition cosmétique pour traiter le cancer du cerveau selon la présente invention sont efficaces pour inhiber la croissance et provoquer la mort des cellules cancéreuses; cela permet de les utiliser efficacement pour prévenir et guérir le cancer du cerveau.
PCT/KR2012/001082 2011-02-11 2012-02-13 Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin Ceased WO2012108748A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110012224A KR101790738B1 (ko) 2011-02-11 2011-02-11 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
KR10-2011-0012224 2011-02-11

Publications (2)

Publication Number Publication Date
WO2012108748A2 WO2012108748A2 (fr) 2012-08-16
WO2012108748A3 true WO2012108748A3 (fr) 2012-12-27

Family

ID=46639103

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/001082 Ceased WO2012108748A2 (fr) 2011-02-11 2012-02-13 Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin

Country Status (2)

Country Link
KR (1) KR101790738B1 (fr)
WO (1) WO2012108748A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816498A (zh) 2009-04-27 2016-08-03 玫琳凯有限公司 植物性抗痤疮制剂
US9138401B2 (en) 2011-12-19 2015-09-22 Mary Kay Inc. Combination of plant extracts to improve skin tone
CN103006752B (zh) * 2012-11-19 2014-12-24 江苏大学 一种合欢皮抗肿瘤有效组分提取物及其制法和用途
CN114656575B (zh) * 2022-03-07 2022-12-06 中国科学院上海药物研究所 一种合欢花非均一多糖，其制备方法及用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020080657A (ko) * 2001-04-17 2002-10-26 주식회사 참 존 합환피 추출물을 함유하는 항산화 화장료
KR100605115B1 (ko) * 2004-03-16 2006-07-28 주식회사 오스코텍 합환피 추출물을 유효성분으로 함유하는 면역억제제

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020080657A (ko) * 2001-04-17 2002-10-26 주식회사 참 존 합환피 추출물을 함유하는 항산화 화장료
KR100605115B1 (ko) * 2004-03-16 2006-07-28 주식회사 오스코텍 합환피 추출물을 유효성분으로 함유하는 면역억제제

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHOI, BYUNG DON ET AL.: "Cytotoxicity of the Components of Albizziajulibrissin", THE JOURNAL OF APPLIED PHARMACOLOGY, vol. 7, 1999, pages 371 - 376 *
KANG, BYUNG SOO ET AL.: "Cytotoxic Activties and Antioxidative Activties Against Liver Cancer Cell of Albizzia root", THE JOURNAL OF APPLIED PHARMACOLOGY, vol. 10, 2002, pages 371 - 376 *

Also Published As

Publication number Publication date
KR101790738B1 (ko) 2017-10-27
WO2012108748A2 (fr) 2012-08-16
KR20120092283A (ko) 2012-08-21

Similar Documents

Publication Publication Date Title
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2012104007A3 (fr) Dérivés de 7-azaindole
WO2013188813A3 (fr) Nouveaux agents thérapeutiques pour le cancer du cerveau
WO2013055899A3 (fr) Compositions utiles pour le traitement d'une néphropathie et leurs procédés de préparation
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2012040804A3 (fr) Combinaisons synergiques de triazoles, strobilurines et de benzimidazoles, leurs utilisations, formulations, leurs procédés de production et leurs applications
WO2013023084A3 (fr) Procédés et compositions pour l'inhibition de la croissance et/ou de la prolifération de cellules tumorales activées par myc
PH12013500738A1 (en) Brimonidine gel compositions and methods of use
WO2013123249A3 (fr) Formulations et méthodes de traitement d'états de l'oreille
IN2014MN02269A (fr)
EP2575842A4 (fr) Composition comprenant l'extrait de physalis alkekengi var. francheti hort en tant que principe actif pour la prévention et le traitement de maladies inflammatoires
WO2012134169A3 (fr) Composition pour le traitement du cancer du poumon et aliment fonctionnel contenant un extrait de semence de gleditsiae
WO2012108748A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin
WO2012108749A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de graines de pharbitis
WO2013028904A3 (fr) Compositions de comblement dermique contenant des antioxydants
WO2013155465A8 (fr) Dérivés de xanthine substituée
PL2695603T3 (pl) Synergistyczne formulacje selenopeptydowe do ochrony komórek brodawki skórnej
WO2012134172A3 (fr) Composition contenant, comme ingrédient actif, une fraction d'acétate d'éthyle de schisandra chinensis baill, ou wuweizisu c séparée de la fraction, pour prévenir ou traiter l'obésité
WO2012108747A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de la racine d'helena
WO2012036414A3 (fr) Composition cosmétique comprenant une fraction d'extrait de soja fermenté au titre de principe actif
WO2012108746A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de racine de rubia cordifolia
WO2012108743A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait des graines de pharbitis blanc
WO2012108745A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de gleditsiae semen
WO2012108744A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de la fleur inula
WO2012134252A3 (fr) Composition pour le traitement du cancer du rein et aliment fonctionnel contenant un extrait de semence de cannabis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12744362

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12744362

Country of ref document: EP

Kind code of ref document: A2